Neurocrine Biosciences
NBIX
NBIX
266 hedge funds and large institutions have $7.63B invested in Neurocrine Biosciences in 2018 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 103 increasing their positions, 88 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
0% less funds holding
Funds holding: 267 → 266 (-1)
3.01% less ownership
Funds ownership: 106.18% → 103.16% (-3%)
Holders
266
Holding in Top 10
7
Calls
$68.8M
Puts
$58.6M
Top Buyers
| 1 | +$140M | |
| 2 | +$58.6M | |
| 3 | +$54.5M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$47.2M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$17.9M |
Top Sellers
| 1 | -$69.1M | |
| 2 | -$64.5M | |
| 3 | -$59.3M | |
| 4 |
TCM
TimesSquare Capital Management
New York
|
-$47.3M |
| 5 |
Millennium Management
New York
|
-$33.7M |